Douglas B Given - Net Worth and Insider Trading
Douglas B Given Net Worth
The estimated net worth of Douglas B Given is at least $3 Million dollars as of 2024-11-10. Douglas B Given is the Director of Arrowhead Pharmaceuticals Inc and owns about 129,711 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $3 Million. Details can be seen in Douglas B Given's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas B Given has not made any transactions after 2024-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas B Given
Douglas B Given Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas B Given owns 3 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , VIA Pharmaceuticals Inc (VIAP) , and Aksys Ltd (AKSY) .
Click here to see the complete history of Douglas B Given’s form 4 insider trades.
Insider Ownership Summary of Douglas B Given
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-11 | director |
VIAP | VIA Pharmaceuticals Inc | 2010-11-15 | director |
AKSY | Aksys Ltd | 2006-10-06 | director |
Douglas B Given Latest Holdings Summary
Douglas B Given currently owns a total of 1 stock. Douglas B Given owns 129,711 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 11, 2024, with a value of $3 Million.
Latest Holdings of Douglas B Given
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-11 | 129,711 | 21.89 | 2,839,374 |
Holding Weightings of Douglas B Given
Douglas B Given Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas B Given has made a total of 11 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 1 buys and 10 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 2,911 shares on January 11, 2024, which brought Douglas B Given around $110,793.
Insider Trading History of Douglas B Given
- 1
Douglas B Given Trading Performance
GuruFocus tracks the stock performance after each of Douglas B Given's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas B Given is -32.21%. GuruFocus also compares Douglas B Given's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas B Given within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas B Given's insider trading performs compared to the benchmark.
Performance of Douglas B Given
Douglas B Given Ownership Network
Ownership Network List of Douglas B Given
Ownership Network Relation of Douglas B Given
Douglas B Given Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Douglas B Given is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Douglas B Given made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 161,544 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Douglas B Given Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas B Given. You might contact Douglas B Given via mailing address: C/o Neorx Corp, 410 West Harrison St, Seattle Wa 98119.